Medartis Acquires CADskills to Expand Custom Implant Capabilities

Medartis, a leading Swiss medical device firm specializing in surgical implants, has acquired CADskills, a Belgium-based company focused on personalized implant solutions and titanium additive manufacturing. The acquisition, announced in early March 2023, aims to bolster Medartis’ capabilities in patient-specific implant design and 3D printing technology for extremity and craniomaxillofacial surgery.

While the financial terms of the deal remain undisclosed, the transaction represents a strategic move by Medartis to enhance its product offerings in the high-precision custom implant market. CADskills, founded by Professor Maurice Mommaerts, is recognized for its expertise in additive manufacturing and patient-specific implant design, particularly for complex reconstructive surgical applications.

Medartis operates globally, providing a broad range of surgical implants and instruments, with a focus on innovation and clinical precision. CADskills complements this by delivering advanced titanium printing and personalized implant solutions, addressing clinical needs where off-the-shelf implants are insufficient.

The acquisition strengthens Medartis’ position in the personalized implant segment by integrating CADskills’ design and additive manufacturing technologies. This integration is expected to accelerate the development and delivery of custom-made implants, improving clinical outcomes for complex cases. Medartis also anticipates cross-selling opportunities to its existing customer base and expansion into new clinical accounts across Europe.

Industry trends show increasing demand for patient-specific implants driven by advances in additive manufacturing and a growing emphasis on tailored surgical solutions. Competitors in the medical device sector are similarly investing in personalized implant technologies, making this acquisition a timely strategic enhancement for Medartis.

Operational synergies include consolidating R&D efforts, streamlining titanium implant production, and leveraging shared administrative functions to reduce costs. The combined expertise is expected to improve speed-to-market for innovative implant solutions and foster closer clinical collaboration.

Integration challenges remain, particularly aligning CADskills’ specialized design and manufacturing processes with Medartis’ existing operations and ensuring regulatory compliance across the expanded product portfolio. Cultural integration between the smaller, tech-focused CADskills and the larger Medartis organization will also require careful management.

Looking ahead, Medartis plans to fully integrate CADskills’ technology and team to deliver enhanced patient-specific implants globally. The acquisition positions Medartis to capture higher-margin custom implant segments and differentiate through advanced additive manufacturing capabilities.

Overall, this deal marks a significant step in Medartis’ growth strategy within the medical devices sector, reinforcing its commitment to innovation and personalized patient care.